30Jun 2024

MANAGEMENT OF MEDULLARY THYROID CARCINOMA

  • Specialist General and Laparoscopic Surgeon, HMS-AL Garhoud Hospital - Dubai, UAE.
  • Specialist Obestetrics and Gynecology, Midcare Hospital -Sharjah, UAE.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Medullary thyroid carcinoma (MTC) compromises 3-10% of all thyroid cancers and arises from parafollicular C cells.This study reviews the current management of medullary thyroid carcinoma emphasizing the current practice in the preoperative diagnosis and evaluation of patients with MTC, and surgical treatment options for managing the thyroid and neck lymph nodes.


[Sobhy Mohamed Ismail Amer and Hanaa Mohamed Mansour (2024); MANAGEMENT OF MEDULLARY THYROID CARCINOMA Int. J. of Adv. Res. (Jun). 802-807] (ISSN 2320-5407). www.journalijar.com


SOBHY MOHAMED MOHAMED ISMAIL AMER

United Arab Emirates

DOI:


Article DOI: 10.21474/IJAR01/18942      
DOI URL: http://dx.doi.org/10.21474/IJAR01/18942